according to a poster presented at the Pulmonary Vascular Research Institute 2025 Annual Congress. In this series, we dive into what rheumatologists should know about pulmonary hypertension ...

Pulmonary arterial hypertension (PAH) is a rare and severe lung disease with a life-threatening prognosis. After several ...

In pulmonary hypertension, a combination of metabolic and mechanical dysfunction leads to irreversible vascular damage.

Pulmonary arterial hypertension (PAH) is a rare form of pulmonary hypertension. It occurs because progressive vascular ...

A recent publication in the International Journal of Cardiology, "Pulmonary artery denervation in pulmonary hypertension: A ...

At the root of ARDS is the host vascular response (HVR), an inflammatory ... such as global pandemics and other emerging infectious-disease threats. “Funding from the US Department of Defense ...

The findings from this single-center retrospective study compare outcomes between 2 groups of patients living with connective ...

"For the first time, we have a dietary maneuver that may serve as an effective therapy for the disease," said Chan, who also directs the Vascular Medicine Institute and Center for Pulmonary ...

A recent publication in the International Journal of Cardiology, Pulmonary artery denervation in pulmonary hypertension: A comprehensive meta-analysis, has shed light on the potential of pulmonary ...

The new drug sotatercept stops the remodelling of the pulmonary vessels and even helps patients with advanced pulmonary arterial hypertension (PAH) who have not yet been treated.